Inventor · disambiguated record
Paolo Righi
Also filed as: RIGHI PAOLO
11 granted patents·22 pending applications·368 citations·filing 2003–2022
93Inventor score
Top patents by PatentIndex Score
33 records- 0197US8158781B2Polymorphic forms α, β and γ of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted Apr 17, 2012·27 cites·8 claims
- 0297US7902206B2Polymorphic forms α, β and γ of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Mar 8, 2011·28 cites·57 claims
- 0397US7045620B2Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparationsALFA WASSERMANN SPA·Filed 2003·Granted May 16, 2006·139 cites·20 claims
- 0496US8835452B2Polymorphic forms α, β and γ of rifaximinALFA WASSERMANN SPA·Filed 2012·Granted Sep 16, 2014·15 cites·21 claims
- 0596US7906542B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Mar 15, 2011·40 cites·25 claims
- 0695US8158644B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted Apr 17, 2012·26 cites·20 claims
- 0795US7923553B2Processes for the production of polymorphic forms of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Apr 12, 2011·18 cites·46 claims
- 0895US7612199B2Polymorphic forms α, β, and γ of rifaximinALFA WASSERMANN SPA·Filed 2009·Granted Nov 3, 2009·45 cites·7 claims
- 0993US8853231B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinALFA WASSERMANN SPA·Filed 2012·Granted Oct 7, 2014·15 cites·18 claims
- 1092US8173801B2Processes for the production of polymorphic forms of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted May 8, 2012·14 cites·19 claims
- 1180US2022127283A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2022·Application pending·0 cites
- 1273US2020339599A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 1373US2019263829A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2019·Application pending·0 cites
- 1473US2020339600A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 1572US2015175627A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 1671US2019263830A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2019·Application pending·0 cites
- 1770US2019135831A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2018·Application pending·0 cites
- 1868US2019135830A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2018·Application pending·0 cites
- 1967US8765778B2Rifamycin derivativesALFA WASSERMANN SPA·Filed 2012·Granted Jul 1, 2014·1 cites·29 claims
- 2067US2018065987A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2017·Application pending·0 cites
- 2167US2008262024A1Rifaximin compositions and method of useVISCOMI GIUSEPPE CLAUDIO·Filed 2008·Application pending·0 cites
- 2267US2015182508A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 2366US2012203000A1Polymorphic forms alpha, beta and gamma of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 2466US2017210758A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
- 2565US2018065988A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2017·Application pending·0 cites
- 2663US2017210757A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
- 2762US2012202989A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 2858US2005272754A1Polymorphic forms of rifaximin, processes for their production and uses thereofALFA WASSERMANN SPA·Filed 2005·Application pending·0 cites
- 2957US2012258166A1Rifaximin compositions and method of useVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 3057US2022119410A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2021·Application pending·0 cites
- 3156US2012035202A1Rifaximin compositions and method of useVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Application pending·0 cites
- 3254US2012214989A1Processes for the production of polymorphic forms of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 3354US2011086871A1Rifaximin compositions and method of useALFA WASSERMANN SPA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paolo Righi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →